Market Overview:
The global mouse ELISA kits market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for ELISA kits for research and diagnostic applications. The unconjugated type segment is expected to dominate the global mouse ELISA kits market during the forecast period, owing to its high accuracy and sensitivity. In terms of application, hospitals & diagnostic laboratories are expected to account for the largest share of the global mouse ELISA kits market during the forecast period.
Product Definition:
Mouse ELISA Kits are used to detect and quantify the presence of mouse antibodies in a given sample. The kits can be used to diagnose various diseases or conditions, as well as to monitor the effectiveness of treatments.
Unconjugated:
Unconjugated antibodies are those that remain attached to the antigen they are raised against. They can be used in immunoassay, as an aid in the detection of disease producing cells or proteins, and for therapeutic drug monitoring. Unconjugated antibodies have a wide range of applications such as research & diagnostic laboratories, clinical diagnostics market and pharmaceutical industries.
Alkaline Phosphatase:
Alkaline phosphatase is an enzyme that catalyzes the hydrolysis of particular phosphate esters to form acid and alcohol. It is used as a measure for the level of protein in biological fluids such as serum, plasma, and urine.
Application Insights:
The research institutes segment dominated the global market in 2017. The growth of this segment can be attributed to the increasing government funding for stem cell research and rising number of R&D laboratories globally. For instance, as per the statistics published by SCRIPPS in 2018, there are over 17000 researchers working in over 7700 institutions across more than 150 countries worldwide. Such a large base of researchers is fueling product demand from research institutes.
Moreover, pharmaceutical and biotechnology companies are also increasingly using immunoassays for drug discovery & development programs at various stages from target identification to clinical trials stage which is further driving product demand globally. For instance, during preclinical studies it has been observed that ELISA assays provide reliable results within 5 minutes which is an important factor while conducting sensitive & rapid screening tests during animal testing phase of new drugs process (Preclinical Testing). Thus such factors are contributing towards revenue generation globally through this application segment.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biotechnology and pharmaceutical companies, coupled with high R&D investment by these firms, has fueled the growth of this regional market. In addition, increasing government funding for research activities is also expected to have a positive impact on industry growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by major players in this region along with growing demand for diagnostic products and reagents generated from Asia Pacific Economic Cooperation (APEC) region itself which includes China, Japan and India among other countries. These factors are expected to boost revenue generation in APAC during the forecast period.
Growth Factors:
- Increasing demand for early diagnosis of various diseases
- Rising prevalence of target diseases
- Technological advancements in ELISA kits
- Growing number of research institutes and laboratories
- Increasing funding for life science research
Scope Of The Report
Report Attributes
Report Details
Report Title
Mouse ELISA Kits Market Research Report
By Type
Unconjugated, Alkaline Phosphatase, Biotin, Others
By Application
Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes, Others
By Companies
Abbexa Ltd, Abcam, Abnova Corporation, Antibodies-online, Antigenix America Inc., Aviva Systems Biology, Bioassay Technology Laboratory, Biomatik, Biorbyt, BioVision, BosterBio, Cell Signaling Technology, CUSABIO Technology LLC, DLdevelop, G Biosciences, GenWay Biotech, Inc., LifeSpan BioSciences, MyBioSource.com, Nordic BioSite, Novus Biologicals, OriGene Technologies, R&D Systems, RayBiotech, Reddot Biotech, Thermo Fisher Scientific, XpressBio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Mouse ELISA Kits Market Report Segments:
The global Mouse ELISA Kits market is segmented on the basis of:
Types
Unconjugated, Alkaline Phosphatase, Biotin, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbexa Ltd
- Abcam
- Abnova Corporation
- Antibodies-online
- Antigenix America Inc.
- Aviva Systems Biology
- Bioassay Technology Laboratory
- Biomatik
- Biorbyt
- BioVision
- BosterBio
- Cell Signaling Technology
- CUSABIO Technology LLC
- DLdevelop
- G Biosciences
- GenWay Biotech, Inc.
- LifeSpan BioSciences
- MyBioSource.com
- Nordic BioSite
- Novus Biologicals
- OriGene Technologies
- R&D Systems
- RayBiotech
- Reddot Biotech
- Thermo Fisher Scientific
- XpressBio
Highlights of The Mouse ELISA Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Unconjugated
- Alkaline Phosphatase
- Biotin
- Others
- By Application:
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology
- Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mouse ELISA Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mouse ELISA Kits are a type of assay that uses antibodies to detect the presence of mouse proteins in a sample.
Some of the key players operating in the mouse elisa kits market are Abbexa Ltd, Abcam, Abnova Corporation, Antibodies-online, Antigenix America Inc., Aviva Systems Biology, Bioassay Technology Laboratory, Biomatik, Biorbyt, BioVision, BosterBio, Cell Signaling Technology, CUSABIO Technology LLC, DLdevelop, G Biosciences, GenWay Biotech, Inc., LifeSpan BioSciences, MyBioSource.com, Nordic BioSite, Novus Biologicals, OriGene Technologies, R&D Systems, RayBiotech, Reddot Biotech, Thermo Fisher Scientific, XpressBio.
The mouse elisa kits market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mouse ELISA Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mouse ELISA Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mouse ELISA Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mouse ELISA Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mouse ELISA Kits Market Size & Forecast, 2018-2028
4.5.1 Mouse ELISA Kits Market Size and Y-o-Y Growth
4.5.2 Mouse ELISA Kits Market Absolute $ Opportunity
Chapter 5 Global Mouse ELISA Kits Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mouse ELISA Kits Market Size Forecast by Type
5.2.1 Unconjugated
5.2.2 Alkaline Phosphatase
5.2.3 Biotin
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mouse ELISA Kits Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mouse ELISA Kits Market Size Forecast by Applications
6.2.1 Hospitals & Diagnostic Laboratories
6.2.2 Pharmaceutical & Biotechnology
6.2.3 Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mouse ELISA Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mouse ELISA Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mouse ELISA Kits Analysis and Forecast
9.1 Introduction
9.2 North America Mouse ELISA Kits Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mouse ELISA Kits Market Size Forecast by Type
9.6.1 Unconjugated
9.6.2 Alkaline Phosphatase
9.6.3 Biotin
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mouse ELISA Kits Market Size Forecast by Applications
9.10.1 Hospitals & Diagnostic Laboratories
9.10.2 Pharmaceutical & Biotechnology
9.10.3 Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mouse ELISA Kits Analysis and Forecast
10.1 Introduction
10.2 Europe Mouse ELISA Kits Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mouse ELISA Kits Market Size Forecast by Type
10.6.1 Unconjugated
10.6.2 Alkaline Phosphatase
10.6.3 Biotin
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mouse ELISA Kits Market Size Forecast by Applications
10.10.1 Hospitals & Diagnostic Laboratories
10.10.2 Pharmaceutical & Biotechnology
10.10.3 Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mouse ELISA Kits Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mouse ELISA Kits Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mouse ELISA Kits Market Size Forecast by Type
11.6.1 Unconjugated
11.6.2 Alkaline Phosphatase
11.6.3 Biotin
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mouse ELISA Kits Market Size Forecast by Applications
11.10.1 Hospitals & Diagnostic Laboratories
11.10.2 Pharmaceutical & Biotechnology
11.10.3 Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mouse ELISA Kits Analysis and Forecast
12.1 Introduction
12.2 Latin America Mouse ELISA Kits Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mouse ELISA Kits Market Size Forecast by Type
12.6.1 Unconjugated
12.6.2 Alkaline Phosphatase
12.6.3 Biotin
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mouse ELISA Kits Market Size Forecast by Applications
12.10.1 Hospitals & Diagnostic Laboratories
12.10.2 Pharmaceutical & Biotechnology
12.10.3 Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mouse ELISA Kits Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mouse ELISA Kits Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mouse ELISA Kits Market Size Forecast by Type
13.6.1 Unconjugated
13.6.2 Alkaline Phosphatase
13.6.3 Biotin
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mouse ELISA Kits Market Size Forecast by Applications
13.10.1 Hospitals & Diagnostic Laboratories
13.10.2 Pharmaceutical & Biotechnology
13.10.3 Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mouse ELISA Kits Market: Competitive Dashboard
14.2 Global Mouse ELISA Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbexa Ltd
14.3.2 Abcam
14.3.3 Abnova Corporation
14.3.4 Antibodies-online
14.3.5 Antigenix America Inc.
14.3.6 Aviva Systems Biology
14.3.7 Bioassay Technology Laboratory
14.3.8 Biomatik
14.3.9 Biorbyt
14.3.10 BioVision
14.3.11 BosterBio
14.3.12 Cell Signaling Technology
14.3.13 CUSABIO Technology LLC
14.3.14 DLdevelop
14.3.15 G Biosciences
14.3.16 GenWay Biotech, Inc.
14.3.17 LifeSpan BioSciences
14.3.18 MyBioSource.com
14.3.19 Nordic BioSite
14.3.20 Novus Biologicals
14.3.21 OriGene Technologies
14.3.22 R&D Systems
14.3.23 RayBiotech
14.3.24 Reddot Biotech
14.3.25 Thermo Fisher Scientific
14.3.26 XpressBio
